Pure Global

WATCHMAN FLXโ„ข Pro Left Atrial Appendage Closure Device with Delivery System - Cardiac occluder - ARTG 464147

Access comprehensive regulatory information for WATCHMAN FLXโ„ข Pro Left Atrial Appendage Closure Device with Delivery System - Cardiac occluder in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is registered under ARTG number 464147 and sponsored by Boston Scientific Pty Ltd, manufactured by Boston Scientific Corporation in United States of America. The device registration started on October 11, 2024.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class I
ARTG 464147
Class I
WATCHMAN FLXโ„ข Pro Left Atrial Appendage Closure Device with Delivery System - Cardiac occluder
ARTG ID: 464147
Good Name: Boston Scientific Pty Ltd - WATCHMAN FLXโ„ข Pro Left Atrial Appendage Closure Device with Delivery System - Cardiac occluder
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

WATCHMAN FLX Pro is intended for percutaneous, transcatheter closure of the left atrial appendage.

Device Classification
Risk Class
Class I
Product Type
Medical device system
ARTG Category
General-Export
Registration Information
ARTG ID
464147
Start Date
October 11, 2024
Effective Date
October 11, 2024
Manufacturer
Country
United States of America
Address
300 Boston Scientific Way, Marlborough, MA, 01752